Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2000 June;44(2) > The Quarterly Journal of Nuclear Medicine 2000 June;44(2):105-11

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

  ECONOMICS OF NUCLEAR MEDICINE
Guest Editor: Gambhir S. S.


The Quarterly Journal of Nuclear Medicine 2000 June;44(2):105-11

language: English

Health technology assessment

Papatheofanis F. J.

From the Department of Radiology The Advanced Medical Technology Assessment and Policy Program UCSD School of Medicine, San Diego, CA, USA


FULL TEXT  


The devel­op­ing ­role and use of diag­nos­tic imag­ing con­tin­ue to ­emerge as dis­ease man­age­ment par­a­digms are ­refined and clin­i­cal guide­lines are ­em-ployed ­more ­often. Health tech­nol­o­gy assess­ment, HTA (­also ­known as ­health ­care tech­nol­o­gy assess­ment), is fun­da­men­tal­ly a ­form of pol­i­cy ­research. By for­mu­lat­ing effe­ctive HTA, the ­short- and ­long-­term effe­cts of ­health ­care tech­nol­o­gy are stud­ied in a system­at­ic and mul­ti­dis­ci­pli­nary way. The fun­da­men­tal aim of all HTA is to ­assist ­those indi­vid­u­als and organ­iza­tions who ­stand to ben­e­fit ­from a new ­health tech­nol­o­gy (­patients), ­those who ­will ­apply the tech­nol­o­gy (pro­vid­ers), and ­those who ­will pay for it (pay­ers) to ­make bet­ter deci­sions ­about the tech­nol­o­gy ­they uti­lize by sup­ply­ing infor­ma­tion ­that is of a ­high sci­en­tif­ic stan­dard and pop­u­la­tion-­based. Effective HTA is espe­cial­ly use­ful to ­health ­care pro­vid­ers, pay­ers, pro­fes­sion­al ­groups in ­health ­care, man­u­fac­tur­ers, polit­i­cal deci­sion-mak­ers and the gen­er­al pub­lic or con­su­mers of ­health ­care tech­nol­o­gy ­because it rep­re­sents a pro­cess ­through ­which effec­tive tech­nol­o­gy can be iden­ti­fied and inef­fe­c­tive tech­nol­o­gy can be under­stood in the con­text of its lim­i­ta­tions. HTA is a mul­ti­dis­ci­pli­nary under­tak­ing requir­ing com­bined exper­tise in clin­i­cal med­i­cine, epi­dem­i­ol­o­gy, bio­sta­tis­tics, bio­en­gi­neer­ing, ­health eco­nom­ics, admin­is­tra­tion, psy­chol­o­gy, soci­ol­o­gy, eth­ics and ­legal sci­ence. Additionally, the expe­ri­enc­es and opin­ions of ­health tech­nol­o­gy ­users and con­su­mers of ­health ­care (espe­cial­ly ­patient advo­ca­cy ­groups) are need­ed to ­form an over­all accu­rate under­stand­ing of the tech­nol­o­gy ­under ­review.

top of page

Publication History

Cite this article as

Corresponding author e-mail